Queen's University Belfast-ko ikertzaileekin lankidetzan egindako argitalpenak (48)

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2010

  1. High affinity binding of hydrophobic and autoantigenic regions of proinsulin to the 70 kDa chaperone DnaK

    BMC Biochemistry, Vol. 11, Núm. 1

  2. Inhibition of secretion of interleukin (IL)-12/IL-23 family cytokines by 4-trifluoromethyl-celecoxib is coupled to degradation via the endoplasmic reticulum stress protein HERP

    Journal of Biological Chemistry, Vol. 285, Núm. 10, pp. 6960-6969

2009

  1. Genetic polymorphisms, their allele combinations and IFN-β treatment response in Irish multiple sclerosis patients

    Pharmacogenomics, Vol. 10, Núm. 7, pp. 1177-1186

  2. IL7RA polymorphisms and chronic inflammatory arthropathies

    Tissue Antigens

2008

  1. IL7RA polymorphisms and susceptibility to multiple sclerosis [18]

    New England Journal of Medicine

  2. Interferon gamma allelic variants: Sex-biased multiple sclerosis susceptibility and gene expression

    Archives of Neurology, Vol. 65, Núm. 3, pp. 349-357

  3. Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine

    British Journal of Clinical Pharmacology, Vol. 66, Núm. 4, pp. 517-528

  4. Refining genetic associations in multiple sclerosis

    The Lancet Neurology

  5. Signalling, inflammation and arthritis: Crossed signals: The role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity

    Rheumatology, Vol. 47, Núm. 6, pp. 771-776

2007

  1. CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland

    Journal of Neuroimmunology, Vol. 187, Núm. 1-2, pp. 187-191

  2. Corrigendum to "Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans" [J. Neuroimmunol. 179 (2006) 108-116] (DOI:10.1016/j.jneuroim.2006.06.003)

    Journal of Neuroimmunology

  3. ITGA4 polymorphisms and susceptibility to multiple sclerosis

    Journal of Neuroimmunology, Vol. 189, Núm. 1-2, pp. 151-157

  4. Pharmacogenomics of Type I interferon therapy: A survey of response-modifying genes

    Cytokine and Growth Factor Reviews

  5. Study of polymorphisms in the interleukin-4 and IL-4 receptor genes in a population of Brazilian patients with multiple sclerosis

    Arquivos de Neuro-Psiquiatria, Vol. 65, Núm. 1, pp. 15-19

  6. The MHC2TA -168A/G and +1614G/C polymorphisms and risk for multiple sclerosis or chronic inflammatory arthropathies

    Tissue Antigens, Vol. 70, Núm. 3, pp. 247-251

  7. The neuropeptide genes TAC1, TAC3, TAC4, VIP and PACAP(ADCYAP1), and susceptibility to multiple sclerosis

    Journal of Neuroimmunology, Vol. 183, Núm. 1-2, pp. 208-213

2006

  1. Celecoxib inhibits interleukin-12 αβ and β2 folding and secretion by a novel COX2-independent mechanism involving chaperones of the endoplasmic reticulum

    Molecular Pharmacology, Vol. 69, Núm. 5, pp. 1579-1587

  2. Cytokine gene polymorphisms in multifactorial conditions

    CRC Press, pp. 1-459